Aurora Cannabis And Vectura Fertin Pharma Have Announced A Commercial Collaboration With Cogent International Manufacturing
Portfolio Pulse from Benzinga Newsdesk
Aurora Cannabis and Vectura Fertin Pharma have announced a commercial collaboration with Cogent International Manufacturing to launch a CBD lozenge on Aurora's Canadian medical cannabis platform. The agreement has an initial term of 24 months, with the first product expected to launch in late 2024.
August 01, 2024 | 11:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aurora Cannabis has entered into a 24-month commercial collaboration with Vectura Fertin Pharma and Cogent International Manufacturing to launch a CBD lozenge on its Canadian medical cannabis platform. The first product is expected to launch in late 2024.
The partnership allows Aurora to expand its product offerings with minimal additional capital investment, potentially increasing its market share and revenue in the medical cannabis sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100